$KALA
KALA BIO, Inc.

2023 Q3 Form 10-Q Financial Statement

#000155837023013310 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $2.100M
YoY Change -100.0% -100.0% -31.17%
Cost Of Revenue $0.00 $0.00 $1.774M
YoY Change -100.0% -100.0% 74.61%
Gross Profit $0.00 $0.00 $326.0K
YoY Change -100.0% -100.0% -83.98%
Gross Profit Margin 15.52%
Selling, General & Admin $4.952M $4.962M $22.67M
YoY Change -48.14% -78.11% -18.98%
% of Gross Profit 6954.91%
Research & Development $5.554M $4.278M $4.473M
YoY Change 3.02% -4.36% 44.57%
% of Gross Profit 1372.09%
Depreciation & Amortization $80.00K $77.00K $149.0K
YoY Change -47.02% -48.32% -41.34%
% of Gross Profit 45.71%
Operating Expenses $8.762M $9.599M $28.07M
YoY Change -41.54% -65.81% -12.54%
Operating Profit -$8.762M -$9.599M -$25.97M
YoY Change -39.86% -63.04% -10.58%
Interest Expense $1.459M $1.413M $2.207M
YoY Change 0.83% -35.98% 5.55%
% of Operating Profit
Other Income/Expense, Net $58.00K -$814.0K -$2.139M
YoY Change -99.87% -61.94%
Pretax Income -$8.700M -$10.41M -$28.11M
YoY Change -129.92% -62.96% -22.98%
Income Tax
% Of Pretax Income
Net Earnings -$8.704M -$10.41M -$28.11M
YoY Change -129.94% -62.96% -22.98%
Net Earnings / Revenue -1338.62%
Basic Earnings Per Share -$3.41 -$4.36 -$0.38
Diluted Earnings Per Share -$3.41 -$4.36 -$0.38
COMMON SHARES
Basic Shares Outstanding 2.543M 2.349M 73.68M
Diluted Shares Outstanding 2.550M 2.388M 73.68M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.10M $59.18M $44.57M
YoY Change 7.08% 32.78% -70.22%
Cash & Equivalents $56.06M $49.26M $42.57M
Short-Term Investments $9.922M $1.999M
Other Short-Term Assets $1.500M $6.063M $25.10M
YoY Change -95.33% -75.84% 1051.38%
Inventory $25.00K
Prepaid Expenses
Receivables $100.0K $117.0K $13.82M
Other Receivables $200.0K $177.0K $0.00
Total Short-Term Assets $57.90M $65.54M $83.52M
YoY Change -31.62% -21.53% -51.37%
LONG-TERM ASSETS
Property, Plant & Equipment $802.0K $637.0K $891.0K
YoY Change 55.13% -28.51% -73.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $300.0K $328.0K $519.0K
YoY Change -36.84% -36.8% -95.81%
Total Long-Term Assets $3.218M $965.0K $1.461M
YoY Change 213.65% -33.95% -96.66%
TOTAL ASSETS
Total Short-Term Assets $57.90M $65.54M $83.52M
Total Long-Term Assets $3.218M $965.0K $1.461M
Total Assets $61.12M $66.50M $84.98M
YoY Change -28.68% -21.74% -60.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $787.0K $760.0K $10.54M
YoY Change -89.29% -92.79% 270.68%
Accrued Expenses $6.260M $4.902M $18.31M
YoY Change -75.32% -73.22% -13.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $10.30M $9.851M $32.89M
YoY Change -74.4% -70.05% 26.14%
LONG-TERM LIABILITIES
Long-Term Debt $33.88M $33.57M $79.80M
YoY Change -20.55% -57.93% 2.24%
Other Long-Term Liabilities $5.700M $5.588M $3.839M
YoY Change 50.67% 45.56% -85.81%
Total Long-Term Liabilities $39.60M $39.16M $83.64M
YoY Change -14.71% -53.18% -20.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.30M $9.851M $32.89M
Total Long-Term Liabilities $39.60M $39.16M $83.64M
Total Liabilities $49.90M $49.01M $116.5M
YoY Change -42.43% -57.94% -11.18%
SHAREHOLDERS EQUITY
Retained Earnings -$620.8M -$612.1M -$603.4M
YoY Change 8.08% 1.43% 29.3%
Common Stock $3.000K $3.000K $73.00K
YoY Change 200.0% -95.89% 12.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.22M $17.49M -$31.55M
YoY Change
Total Liabilities & Shareholders Equity $61.12M $66.50M $84.98M
YoY Change -28.68% -21.74% -60.56%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$8.704M -$10.41M -$28.11M
YoY Change -129.94% -62.96% -22.98%
Depreciation, Depletion And Amortization $80.00K $77.00K $149.0K
YoY Change -47.02% -48.32% -41.34%
Cash From Operating Activities -$2.950M -$7.595M -$25.42M
YoY Change -81.17% -70.12% 17.64%
INVESTING ACTIVITIES
Capital Expenditures $280.0K $214.0K -$172.0K
YoY Change -836.84% -224.42% -47.08%
Acquisitions
YoY Change
Other Investing Activities $10.00M -$9.819M $3.000M
YoY Change -84.6% -427.3% -86.96%
Cash From Investing Activities $9.720M -$10.03M $2.828M
YoY Change -85.03% -454.77% -87.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.00K 3.073M -10.00K
YoY Change -100.1% -30830.0% -100.17%
NET CHANGE
Cash From Operating Activities -2.950M -7.595M -25.42M
Cash From Investing Activities 9.720M -10.03M 2.828M
Cash From Financing Activities 40.00K 3.073M -10.00K
Net Change In Cash 6.810M -14.56M -22.60M
YoY Change -27.35% -35.6% -427.03%
FREE CASH FLOW
Cash From Operating Activities -$2.950M -$7.595M -$25.42M
Capital Expenditures $280.0K $214.0K -$172.0K
Free Cash Flow -$3.230M -$7.809M -$25.25M
YoY Change -79.33% -69.07% 18.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001479419
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1706971
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2538687
kala Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2023Q2 kala Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2022 kala Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
kala Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2023Q2 kala Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2022 kala Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
kala Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2023Q2 kala Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2022 kala Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0
CY2022Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38150
dei Entity Registrant Name
EntityRegistrantName
KALA BIO, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-0604595
dei Entity Address Address Line1
EntityAddressAddressLine1
1167 Massachusetts Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Arlington
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02476
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
996-5252
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
KALA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2542716
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49256000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70495000
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
9922000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1113000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7852000
CY2023Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
5244000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
7595000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
65535000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
85942000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
637000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
400000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16000
CY2023Q2 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
328000
CY2022Q4 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
462000
CY2023Q2 us-gaap Assets
Assets
66500000
CY2022Q4 us-gaap Assets
Assets
86820000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
760000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2832000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4902000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8910000
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4189000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4189000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4146000
CY2022Q4 kala Deferred Purchase Consideration Current
DeferredPurchaseConsiderationCurrent
595000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9851000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25685000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33569000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
37937000
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
5588000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
4224000
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
39157000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
42161000
CY2023Q2 us-gaap Liabilities
Liabilities
49008000
CY2022Q4 us-gaap Liabilities
Liabilities
67846000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2538687
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1706971
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
629558000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
606182000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-612078000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-587210000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17492000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18974000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66500000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86820000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2100000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3472000
CY2022Q2 kala Product Revenue Cost
ProductRevenueCost
1774000
kala Product Revenue Cost
ProductRevenueCost
2549000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4962000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22673000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10992000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49655000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4278000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4473000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8314000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8939000
CY2022Q2 kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
789000
kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
230000
kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
-262000
CY2023Q2 kala Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
-359000
CY2022Q2 kala Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
59000
kala Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
-2206000
kala Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
1047000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
9599000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
28072000
us-gaap Operating Expenses
OperatingExpenses
21282000
us-gaap Operating Expenses
OperatingExpenses
60358000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9599000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25972000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21282000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56886000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
718000
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
68000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1393000
us-gaap Investment Income Interest
InvestmentIncomeInterest
76000
CY2023Q2 us-gaap Interest Expense
InterestExpense
1413000
CY2022Q2 us-gaap Interest Expense
InterestExpense
2207000
us-gaap Interest Expense
InterestExpense
2887000
us-gaap Interest Expense
InterestExpense
4242000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-119000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2092000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-814000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2139000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3586000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4166000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10413000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28111000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24868000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61052000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.36
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.36
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-18.92
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-18.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-41.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-41.10
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2387793
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2387793
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1485888
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1485888
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2229370
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2229370
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1485530
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1485530
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10413000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28111000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24868000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61052000
CY2023Q2 kala Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
9000
CY2022Q2 kala Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
1000
kala Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
9000
kala Other Comprehensive Income Available For Sale Securities Adjustments Net Of Tax Portions Attributable To Parent
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentsNetOfTaxPortionsAttributableToParent
-1000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10404000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28110000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24859000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61053000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23461000
CY2023Q2 kala Payments Of Stock Issuance Costs At Market Offering
PaymentsOfStockIssuanceCostsAtMarketOffering
62000
CY2023Q2 kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
3073000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1362000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10413000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17492000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5284000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1840000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-28111000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-31554000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18974000
kala Payments Of Stock Issuance Costs At Market Offering
PaymentsOfStockIssuanceCostsAtMarketOffering
446000
kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
17966000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
365000
kala Asset Acquisition Contingent Milestone Consideration Equity Interest Issued Or Issuable
AssetAcquisitionContingentMilestoneConsiderationEquityInterestIssuedOrIssuable
2354000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2686000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000
us-gaap Net Income Loss
NetIncomeLoss
-24868000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
17492000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16804000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
160000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
7936000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4596000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000
us-gaap Net Income Loss
NetIncomeLoss
-61052000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-31554000
us-gaap Profit Loss
ProfitLoss
-24868000
us-gaap Profit Loss
ProfitLoss
-61052000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
154000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
306000
kala Non Cash Operating Lease
NonCashOperatingLease
16000
kala Non Cash Operating Lease
NonCashOperatingLease
403000
kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
230000
kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
-262000
kala Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
-2206000
kala Gain Loss On Fair Value Re Measurement Of Contingent Consideration
GainLossOnFairValueReMeasurementOfContingentConsideration
1047000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
632000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
871000
us-gaap Share Based Compensation
ShareBasedCompensation
2686000
us-gaap Share Based Compensation
ShareBasedCompensation
4721000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
47000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
27000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-78000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1523000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6665000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3467000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2300000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1584000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
144000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2063000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5643000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4651000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2670000
kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-13000
kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-324000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17279000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49508000
kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
322000
kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
253000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
47000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9866000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4992000
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
3000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10141000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2245000
kala Payment Of Principal On Venture Debt Facility
PaymentOfPrincipalOnVentureDebtFacility
10000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17966000
kala Payment O Cash Portion Of Dosing Milestone
PaymentOCashPortionOfDosingMilestone
2041000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
19000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
163000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5931000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
144000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21489000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51609000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70745000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94878000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49256000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43269000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49256000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43269000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
700000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49256000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42569000
kala Capital Expenditures Incurred But Not Yet Paid Accounts Payable
CapitalExpendituresIncurredButNotYetPaidAccountsPayable
50000
kala Capital Expenditures Incurred But Not Yet Paid Accounts Payable
CapitalExpendituresIncurredButNotYetPaidAccountsPayable
139000
kala Issuance Of Common Stock To Satisfy Deferred Purchase Consideration In Additional Paid In Capital
IssuanceOfCommonStockToSatisfyDeferredPurchaseConsiderationInAdditionalPaidInCapital
365000
kala Asset Acquisition Contingent Milestone Consideration Equity Interest Issued Or Issuable
AssetAcquisitionContingentMilestoneConsiderationEquityInterestIssuedOrIssuable
2354000
us-gaap Interest Paid Net
InterestPaidNet
2334000
us-gaap Interest Paid Net
InterestPaidNet
3315000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
424000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10413000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24868000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28111000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61052000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17279000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49508000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-612078000
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
31000000
CY2022Q3 kala Disposal Group Including Discontinued Operation Number Of Milestone Payments Per Calendar Year
DisposalGroupIncludingDiscontinuedOperationNumberOfMilestonePaymentsPerCalendarYear
1
CY2022Q3 kala Disposal Group Including Discontinued Operation Number Of Milestone Payments Per Calendar Year
DisposalGroupIncludingDiscontinuedOperationNumberOfMilestonePaymentsPerCalendarYear
1
CY2022Q4 kala Due From Alcon
DueFromAlcon
5394000
CY2022Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
26000
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
5244000
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
7544000
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Current
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
51000
CY2023Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5244000
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
7595000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
7935000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
365000
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0
CY2022Q2 kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
789000
kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
230000
kala Gain Loss On Fair Value Re Measurement Of Deferred Purchase Consideration
GainLossOnFairValueReMeasurementOfDeferredPurchaseConsideration
-262000
kala Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2023Q2 kala Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2022 kala Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
9922000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
9922000
kala Investments Contractual Maturity Term
InvestmentsContractualMaturityTerm
P1Y
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
CY2023Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
177000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
908000
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
120000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
698000
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
117000
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
195000
CY2023Q2 kala Due From Alcon
DueFromAlcon
12000
CY2022Q4 kala Due From Alcon
DueFromAlcon
5394000
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
687000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
657000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1113000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7852000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1837000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3334000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
936000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
948000
CY2023Q2 kala Accrued Revenue Reserves
AccruedRevenueReserves
617000
CY2022Q4 kala Accrued Revenue Reserves
AccruedRevenueReserves
807000
CY2023Q2 kala Development Costs Current
DevelopmentCostsCurrent
457000
CY2022Q4 kala Development Costs Current
DevelopmentCostsCurrent
446000
CY2023Q2 kala Accrued Contract Manufacturing
AccruedContractManufacturing
365000
CY2022Q4 kala Accrued Contract Manufacturing
AccruedContractManufacturing
453000
CY2023Q2 kala Accrued Commercialization Cost
AccruedCommercializationCost
254000
CY2022Q4 kala Accrued Commercialization Cost
AccruedCommercializationCost
271000
CY2022Q4 kala Due To Third Party
DueToThirdParty
2244000
CY2023Q2 kala Other Accrued Expenses Current
OtherAccruedExpensesCurrent
436000
CY2022Q4 kala Other Accrued Expenses Current
OtherAccruedExpensesCurrent
407000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4902000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8910000
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
450000
CY2022 kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
4303
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
6000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
219000
us-gaap Operating Lease Cost
OperatingLeaseCost
16000
us-gaap Operating Lease Cost
OperatingLeaseCost
395000
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
92000
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
54000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
112000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
94000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
179000
us-gaap Variable Lease Cost
VariableLeaseCost
6000
us-gaap Variable Lease Cost
VariableLeaseCost
626000
CY2023Q2 us-gaap Lease Cost
LeaseCost
98000
CY2022Q2 us-gaap Lease Cost
LeaseCost
452000
us-gaap Lease Cost
LeaseCost
134000
us-gaap Lease Cost
LeaseCost
1115000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
251000
us-gaap Operating Lease Payments
OperatingLeasePayments
13000
us-gaap Operating Lease Payments
OperatingLeasePayments
970000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
0
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.104
CY2023Q2 kala Area Of Property Leased
AreaOfPropertyLeased
6135
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P62M
CY2023Q2 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3077000
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.1697
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
33957000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
43303000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
670000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
806000
CY2023Q2 kala Debt Instrument Exit Fees Of Total Principal Payments Value
DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue
282000
CY2022Q4 kala Debt Instrument Exit Fees Of Total Principal Payments Value
DebtInstrumentExitFeesOfTotalPrincipalPaymentsValue
440000
CY2023Q2 kala Adjusted Long Term Debt
AdjustedLongTermDebt
33569000
CY2022Q4 kala Adjusted Long Term Debt
AdjustedLongTermDebt
42937000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33569000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
37937000
kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
4303
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75000000
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
565974
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75000000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
112097
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.210
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.231
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0355
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0396
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.83
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1362000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1916000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2686000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4721000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10413000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28111000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24868000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61052000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2387793
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2387793
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1485888
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1485888
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2229370
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2229370
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1485530
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1485530
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.36
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.36
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-18.92
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-18.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-11.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-11.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-41.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-41.10
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6772505
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
265945
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6213659
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
273773
CY2022Q4 kala Tax Credit Carryforward Amount Annual Limitation
TaxCreditCarryforwardAmountAnnualLimitation
222000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0

Files In Submission

Name View Source Status
0001558370-23-013310-index-headers.html Edgar Link pending
0001558370-23-013310-index.html Edgar Link pending
0001558370-23-013310.txt Edgar Link pending
0001558370-23-013310-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kala-20230630.xsd Edgar Link pending
kala-20230630x10q.htm Edgar Link pending
kala-20230630xex10d2.htm Edgar Link pending
kala-20230630xex10d3.htm Edgar Link pending
kala-20230630xex10d4.htm Edgar Link pending
kala-20230630xex10d5.htm Edgar Link pending
kala-20230630xex10d6.htm Edgar Link pending
kala-20230630xex10d7.htm Edgar Link pending
kala-20230630xex10d8.htm Edgar Link pending
kala-20230630xex10d9.htm Edgar Link pending
kala-20230630xex31d1.htm Edgar Link pending
kala-20230630xex31d2.htm Edgar Link pending
kala-20230630xex32d1.htm Edgar Link pending
kala-20230630xex32d2.htm Edgar Link pending
kala-20230630xex3d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kala-20230630_cal.xml Edgar Link unprocessable
kala-20230630_def.xml Edgar Link unprocessable
kala-20230630_lab.xml Edgar Link unprocessable
kala-20230630_pre.xml Edgar Link unprocessable
kala-20230630x10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending